The Adenosine A2B Receptor Drives Osteoclast-Mediated Bone Resorption in Hypoxic Microenvironments
Open Access
Abstract
Osteoclast-mediated bone destruction is amplified in the hypoxic synovial microenvironment of rheumatoid arthritis (RA). This increased bone resorption is driven by the hypoxia-inducible transcription factor HIF. We identified hypoxic induction of the HIF-regulated adenosine A2B receptor in primary human osteoclasts (mRNA, 3.8-fold increase, p < 0.01) and sought to identify the role(s) of purinergic signaling via this receptor in the bone resorption process. Primary human osteoclasts were differentiated from CD14+ monocytes and exposed to hypoxia (2% O2) and A2B receptor inhibitors (MRS1754, PSB603). The hypoxic increase in bone resorption was prevented by the inhibition of the A2B receptor, at least partly by the attenuation of glycolytic and mitochondrial metabolism via inhibition of HIF. A2B receptor inhibition also reduced osteoclastogenesis in hypoxia by inhibiting early cell fusion (day 3–4, p < 0.05). The A2B receptor is only functional in hypoxic or inflammatory environments when the extracellular concentrations of adenosine (1.6-fold increase, p < 0.05) are sufficient to activate the receptor. Inhibition of the A2B receptor under normoxic conditions therefore did not affect any parameter tested. Reciprocal positive regulation of HIF and the A2B receptor in a hypoxic microenvironment thus enhances glycolytic and mitochondrial metabolism in osteoclasts to drive increased bone resorption. A2B receptor inhibition could potentially prevent the pathological osteolysis associated with hypoxic diseases such as rheumatoid arthritis.Keywords
Funding Information
- Arthritis Research UK (MP/19200)
This publication has 53 references indexed in Scilit:
- Differential regulation of HIF‐mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclastsThe Journal of Pathology, 2013
- Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate actionArthritis Research & Therapy, 2012
- Adenosine A2AReceptor Activation Prevents Wear Particle–Induced OsteolysisScience Translational Medicine, 2012
- Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemiaNature Medicine, 2012
- Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signalingPurinergic Signalling, 2012
- Adenosine A2A Receptor Ligation Inhibits Osteoclast FormationThe American Journal of Pathology, 2012
- Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4The FASEB Journal, 2010
- Hypoxia-Inducible Factors and the Response to Hypoxic StressMolecular Cell, 2010
- Adenosine A 1 receptors (A 1 Rs) play a critical role in osteoclast formation and functionThe FASEB Journal, 2010
- Adenosine A1 receptors regulate bone resorption in mice: Adenosine A1 receptor blockade or deletion increases bone density and prevents ovariectomy‐induced bone loss in adenosine A1 receptor–knockout miceArthritis & Rheumatism, 2010